Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic

Part of paid clinical trials in Tucson, Arizona.

Sponsor
NuvOx LLC
Study ID
NCT07417774
Status
Enrolling By Invitation

Conditions

  • Glioblastoma (GBM)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this sub-study of the RESTORE trial is to identify biomarkers associated with tumor hypoxia, identify biomarkers that differentiate pseudoprogression from true progression, and correlate biomarkers with clinical outcomes.

Key Dates

Start date
Dec 8, 2025
Status verified
Feb 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2030

Study Design

Enrollment
40 participants (estimated)

Primary Outcome Measure

Tumor hypoxia biomarkers [ Time Frame: until disease progression and up to 5 years ]

Locations (4)

FacilityCityStateZIPSite coordinators
Center for NeurosciencesTucsonArizona85718-
Yale Cancer CenterNew HavenConnecticut06520-
Saint Luke's Cancer InstituteKansas CityMissouri64111-
Duke University Medical CenterDurhamNorth Carolina27710-

Find similar trials in Tucson, AZ

By research site
Center for Neurosciences· Tucson, AZYale Cancer Center· New Haven, CTSaint Luke's Cancer Institute· Kansas City, MODuke University Medical Center· Durham, NC

Related Studies